Skip to content

Zymeworks ZYME Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$585.5K-11.6%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$96.5K+9.3%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions.

The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's unrecognized tax benefits increases resulting from current period tax positions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's unrecognized tax benefits increases resulting from current period tax positions?
Zymeworks (ZYME) reported unrecognized tax benefits increases resulting from current period tax positions of $24.25K in Q4 2025.
How has Zymeworks's unrecognized tax benefits increases resulting from current period tax positions changed year-over-year?
Zymeworks's unrecognized tax benefits increases resulting from current period tax positions increased by 155.3% year-over-year, from $9.5K to $24.25K.
What is the long-term trend for Zymeworks's unrecognized tax benefits increases resulting from current period tax positions?
Over 2 years (2023 to 2025), Zymeworks's unrecognized tax benefits increases resulting from current period tax positions has grown at a 163.2% compound annual growth rate (CAGR), from $14K to $97K.
What does unrecognized tax benefits increases resulting from current period tax positions mean?
This metric tracks the increase in unrecognized tax benefits arising from new tax positions taken during the current reporting period. It reflects the company's conservative or aggressive stance on uncertain tax matters. An increase suggests a higher level of tax uncertainty or the adoption of new, complex tax strategies.